Oncology PracticeNovel antibody shifts ‘eat me/don’t eat me’ balance in refractory NHLJune 6, 2018Immuno-oncologyLymphoma & Plasma Cell DisordersAggressive LymphomasFollicular Lymphoma
Hospital Physician: Hematology/OncologyAggressive B-Cell Non-Hodgkin LymphomaJune 4, 2018Lymphoma & Plasma Cell DisordersFollicular LymphomaB Cell Lymphoma
Hematology TimesUmbralisib has ‘distinct’ safety profileMay 16, 2018Lymphoma & Plasma Cell DisordersHodgkin LymphomaNon-Hodgkin LymphomaAggressive LymphomasFollicular Lymphoma
The Journal of Community and Supportive Oncology2017 notches up some landmark approvalsMay 14, 2018Breast CancerLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersFollicular Lymphoma
Hematology TimesDrug granted fast track designations for FL, DLBCLMay 5, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive LymphomasFollicular Lymphoma
Hematology NewsEarly results favor combo IL-15/anti-CD20 in indolent NHLMay 3, 2018Indolent LymphomaLymphoma & Plasma Cell DisordersFollicular Lymphoma
Hematology NewsNovartis CAR T-cell therapy adds a lymphoma indicationMay 3, 2018Aggressive LymphomasLymphoma & Plasma Cell DisordersFollicular LymphomaB Cell Lymphoma
Hematology TimesFDA issues CRL for proposed biosimilar rituximabMay 3, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive LymphomasFollicular Lymphoma
Hematology TimesFDA approves CAR T-cell therapy for lymphomaMay 2, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive LymphomasFollicular LymphomaB Cell Lymphoma
Hematology TimesTeam identifies 5 subtypes of DLBCLMay 1, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive LymphomasFollicular Lymphoma
Hematology NewsFDA places partial hold on trials after secondary lymphomaApril 25, 2018T Cell LymphomasAggressive LymphomasLymphoma & Plasma Cell DisordersFollicular Lymphoma
Hematology TimesInhibitor outperforms rivals in leukemia, lymphomaApril 20, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersAMLNon-Hodgkin LymphomaAggressive LymphomasFollicular Lymphoma
Hematology NewsPDPK1 could be novel target in MCLApril 13, 2018Mantle Cell LymphomaAggressive LymphomasLymphoma & Plasma Cell DisordersFollicular Lymphoma
Hematology NewsFDA grants priority review of follicular lymphoma drugApril 11, 2018Indolent LymphomaLymphoma & Plasma Cell DisordersFollicular Lymphoma
Hematology TimesTazemetostat exhibits antitumor activity in phase 1 trialApril 11, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive LymphomasFollicular Lymphoma
